These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 26924839)
21. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related]
22. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Diener HC; Gendolla A; Gebert I; Beneke M Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337 [TBL] [Abstract][Full Text] [Related]
23. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. Fullerton T; Komorowski-Swiatek D; Forrest A; Gengo FM J Clin Pharmacol; 1999 Jan; 39(1):17-29. PubMed ID: 9987697 [TBL] [Abstract][Full Text] [Related]
24. Nitroglycerin provocation in normal subjects is not a useful human migraine model? Tvedskov JF; Iversen HK; Olesen J; Tfelt-Hansen P Cephalalgia; 2010 Aug; 30(8):928-32. PubMed ID: 19740120 [TBL] [Abstract][Full Text] [Related]
25. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea. Schulman EA Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837 [TBL] [Abstract][Full Text] [Related]
26. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444 [TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
32. High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group. Pini LA; Sternieri E; Fabbri L; Zerbini O; Bamfi F J Int Med Res; 1995; 23(2):96-105. PubMed ID: 7601299 [TBL] [Abstract][Full Text] [Related]
33. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Linde M; Mellberg A; Dahlöf C Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264 [TBL] [Abstract][Full Text] [Related]
35. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Dowson AJ; Massiou H; Lainez JM; Cabarrocas X Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355 [TBL] [Abstract][Full Text] [Related]
36. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model. Martelletti P; Stirparo G; Rinaldi C; Fusco BM Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea. Allais G; Castagnoli Gabellari I; Rolando S; Benedetto C Expert Rev Neurother; 2011 Oct; 11(10):1383-7. PubMed ID: 21955195 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078 [TBL] [Abstract][Full Text] [Related]
40. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Gomez-Mancilla B; Brand R; Jürgens TP; Göbel H; Sommer C; Straube A; Evers S; Sommer M; Campos V; Kalkman HO; Hariry S; Pezous N; Johns D; Diener HC; Cephalalgia; 2014 Feb; 34(2):103-13. PubMed ID: 23963355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]